Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation

Name: Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
Published: 2016
License: Public Domain

University Hospital, Brest · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

cystic-fibrosis

cystic fibrosis, roscovitine, seliciclib, cyc202, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation

Related documents